PARAMUS, N.J.--(BUSINESS WIRE)--EnzymeRx today announced two significant additions to its management team. Joining EnzymeRx as Vice President, Manufacturing is Elizabeth John, Ph.D. Elizabeth has most recently served as Head of Research and Development at Centegen, a biotechnology start-up. She brings 17 years of experience in the manufacture of biologics and the regulation of biologics manufacturing to EnzymeRx, and in her career has contributed to multiple INDs, managed drug development programs, and has interacted closely with the FDA and foreign regulatory agencies. Elizabeth received her Ph.D. in Chemistry from Rutgers University and completed post-doctoral training in radiopharmaceutical chemistry at Purdue University. She also received an M.S. in Chemistry from the Indian Institute of Technology in Madras.
